Independent Director · BeOne Medicines Ltd. (ONC)

Michael Goller director compensation at BeOne Medicines: $485K

Fiscal year 2025 director compensation for Michael Goller at BeOne Medicines Ltd.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 28, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get Michael Goller’s full pay file as a PDF — free

More than this page: up to 10 years of Michael’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Michael Goller and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

BeOne Medicines Director Compensation Table · all 4 fiscal years held
In US dollars, as BeOne Medicines reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$85,000$199,834$199,954$0$484,788
FY2024$84,750$199,901$199,995—$484,646
FY2022$76,500$199,893$199,967$0$476,360
FY2021$73,000$199,992$199,990$0$472,982

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: BeOne Medicines Ltd. DEF 14A filed April 28, 2026, accession 0001104659-26-049655, and prior-year filings. Open the filing on EDGAR.

How this page was built: the BeOne Medicines Ltd. filed document, accession 0001104659-26-049655. Every figure is read from that document and cited to the page and table it appears in. Filed April 28, 2026.

Get the BeOne Medicines Board Governance Report

$484,788 Michael Goller, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 28, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

BeOne Medicines pays directors a $65,000 cash retainer and $400,000 in equity.

Committees

FY2025 · as the proxy prints them

Nominating/Governance · Scientific Advisory

The rest of the BeOne Medicines board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Alessandro RivaIndependent Director$494,788
Anthony C. HooperIndependent Director$528,129
Charles L. SawyersIndependent Director—
Corazon (Corsee) D. SandersIndependent Director$502,288
Elizabeth F. MooneyIndependent Director—
Felix J. BakerIndependent Director—
John V. OylerChair of the Board—
Margaret DuganIndependent Director$514,788
Olivier BrandicourtIndependent Director$492,288
Qingqing YiIndependent Director$489,788
Ranjeev KrishanaIndependent Director$489,788
Shalini SharpIndependent Director$525,165
Xiaodong WangDirector$4,249,830

The full BeOne Medicines compensation record

free company brief

This page is one director within BeOne Medicines's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the BeOne Medicines proxy · each links to its own free brief

Order ONC

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report